Steris PLC (STE) Shares Sold by Rice Hall James & Associates LLC

Rice Hall James & Associates LLC lessened its stake in shares of Steris PLC (NYSE:STE) by 8.4% in the third quarter, Holdings Channel reports. The institutional investor owned 26,428 shares of the medical equipment provider’s stock after selling 2,435 shares during the quarter. Rice Hall James & Associates LLC’s holdings in Steris were worth $3,023,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. BlackRock Inc. boosted its position in Steris by 1.8% during the second quarter. BlackRock Inc. now owns 7,608,114 shares of the medical equipment provider’s stock worth $798,929,000 after purchasing an additional 131,142 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Steris by 4.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 2,269,194 shares of the medical equipment provider’s stock worth $259,595,000 after purchasing an additional 103,392 shares during the period. Bessemer Group Inc. boosted its position in Steris by 1.2% during the second quarter. Bessemer Group Inc. now owns 1,350,926 shares of the medical equipment provider’s stock worth $141,863,000 after purchasing an additional 16,460 shares during the period. Wells Fargo & Company MN boosted its position in Steris by 6.8% during the second quarter. Wells Fargo & Company MN now owns 1,289,590 shares of the medical equipment provider’s stock worth $135,421,000 after purchasing an additional 81,588 shares during the period. Finally, Victory Capital Management Inc. boosted its position in Steris by 2.3% during the second quarter. Victory Capital Management Inc. now owns 1,253,500 shares of the medical equipment provider’s stock worth $131,630,000 after purchasing an additional 27,700 shares during the period. Institutional investors and hedge funds own 88.76% of the company’s stock.

Shares of NYSE:STE opened at $105.82 on Friday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.65 and a quick ratio of 2.02. The stock has a market cap of $8.95 billion, a price-to-earnings ratio of 24.61 and a beta of 1.06. Steris PLC has a twelve month low of $82.88 and a twelve month high of $117.48.



Steris (NYSE:STE) last issued its earnings results on Wednesday, August 8th. The medical equipment provider reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.99 by $0.01. Steris had a net margin of 11.42% and a return on equity of 11.80%. The firm had revenue of $638.76 million during the quarter, compared to analyst estimates of $638.63 million. During the same quarter last year, the business earned $0.85 earnings per share. The company’s quarterly revenue was up 5.1% on a year-over-year basis. Analysts predict that Steris PLC will post 4.71 EPS for the current fiscal year.

In other news, VP Karen L. Burton sold 1,300 shares of the firm’s stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $114.39, for a total value of $148,707.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.38% of the stock is currently owned by company insiders.

A number of equities analysts have weighed in on the stock. Zacks Investment Research upgraded shares of Steris from a “sell” rating to a “hold” rating in a research report on Tuesday, October 9th. JMP Securities increased their target price on shares of Steris from $113.00 to $125.00 and gave the stock a “market outperform” rating in a research report on Thursday, August 9th. KeyCorp increased their target price on shares of Steris from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 9th. Finally, Stephens reiterated a “buy” rating and set a $125.00 target price on shares of Steris in a research report on Thursday, August 9th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $100.86.

Steris Company Profile

STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.

Featured Article: Does the discount rate affect the economy?

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).

Institutional Ownership by Quarter for Steris (NYSE:STE)

Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply